Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research

Global Immunofluorescence Assay Market Is Projected To Grow At A 6.9% Rate Through The Forecast Period

September 20, 2023 07:00 PM IST | By EIN Presswire
Global Immunofluorescence Assay Market Is Projected To Grow At A 6.9% Rate Through The Forecast Period
Image source: EIN Presswire

Recent News

thumbnail

Kashiv BioSciences Announces Positive Topline Results from Confirmator...

thumbnail

KnowBe4 Collaborates With Microsoft to Strengthen Email Security Throu...

thumbnail

NetApp Report Highlights Fierce Competition in Global AI Leadership

thumbnail

IDFC FIRST Bank Introduces UPI Services for NRI Customers Across 12 Co...

The Business Research Company’s Immunofluorescence Assay Global Market Report 2023 – Market Size, Trends, And Forecast 2023-2027

LONDON, GREATER LONDON, UK, September 20, 2023/EINPresswire.com/ -- The "Immunofluorescence Assay Global Market Report 2023" offers extensive market insights. TBRC predicts the immunofluorescence assay market to reach $4.1 billion in 2027, with a 6.9% CAGR.

Immunofluorescence assay market grows due to rising chronic diseases. North America leads. Key players: Thermo Fisher Scientific, Abcam plc, Bio-Rad Laboratories, PerkinElmer Inc., Werfen Company, Merck KGaA, Agilent Technologies.

Immunofluorescence Assay Market Segments
• Type: Direct, Indirect Immunofluorescence
• Product: Reagents, Instruments, Antibodies, Kits, Consumables
• Disease: Cancer, Infectious, Cardiovascular, Autoimmune, Other Diseases
• End User: Academic/Research, Pharma/Biotech, CROs, Hospitals/Diagnostics
• Geography: Segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East, and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

Immunofluorescence assay uses equipment and consumables to visualize proteins and antigens in infected cells through antibody reactions with fluorescent dyes. Used for diagnosing various organ system diseases in the lab.

Read More On The Immunofluorescence Assay Global Market Report At:
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Market Characteristics
3. Immunofluorescence Assay Market Trends And Strategies
4. Immunofluorescence Assay Market – Macro Economic Scenario
5. Market Size And Growth
……
27. Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Immuno-Oncology Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Immunosuppressants Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Immunoglobulins Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Sponsored Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.